Pharmacyclics

Nov 20, 2019

World Renowned Professor of Chemistry and Cancer Survivor, Professor Jonathan Sessler Appointed to the OncoTEX Inc. Board of Directors

Jan 18, 2019

AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Metastatic Pancreatic Cancer

Dec 17, 2018

Arena Pharmaceuticals Appoints Experienced Life Sciences Industry Finance Executive Manmeet S. Soni to Board of Directors

Dec 17, 2018

AbbVie Announces Executive Leadership Changes

Jun 25, 2018

IMBRUVICA® (ibrutinib) Supplemental New Drug Application Accepted for Review by U.S. FDA with Potential to Broaden Treatment Use as a Combination Treatment Option with Rituximab in Waldenström's Macroglobulinemia (WM), A Rare Form of Blood Cancer

Jun 19, 2018

8,000 AbbVie Employees Volunteer Across Five Continents During Fifth-Annual "Week of Possibilities"

Oct 26, 2017

Ibrutinib Market Analysis, Size and Forecast to 2017-2022, Share, Growth and Trends